Zobrazeno 1 - 10
of 14
pro vyhledávání: ''
Publikováno v:
BMC Ophthalmology
BMC Ophthalmology, Vol 21, Iss 1, Pp 1-7 (2021)
BMC Ophthalmology, Vol 21, Iss 1, Pp 1-7 (2021)
BackgroundThe treatment efficacy of botulinum toxin bilateral medial rectus injections for acute acquired concomitant esotropia (AACE) in adult is not clear. We characterize the effects of botulinum toxin injection in the treatment of AACE, especiall
Publikováno v:
BMC Ophthalmology
BMC Ophthalmology, Vol 20, Iss 1, Pp 1-7 (2020)
BMC Ophthalmology, Vol 20, Iss 1, Pp 1-7 (2020)
Background Numerous cytokines have been proven to participate in the pathogenesis of neovascular age-related macular degeneration (nAMD). The present study aimed to investigate the aqueous humor cytokine expression profile in nAMD patients before and
Publikováno v:
BMC Ophthalmology
BMC Ophthalmology, Vol 20, Iss 1, Pp 1-8 (2020)
BMC Ophthalmology, Vol 20, Iss 1, Pp 1-8 (2020)
Background The DRCR.net Protocol T clinical trial assessed the comparative efficacy and safety of anti-VEGF treatments including aflibercept, ranibizumab and bevacizumab in diabetic macular edema (DME). Post -hoc analyses showed that after a 12-week
Publikováno v:
BMC Ophthalmology
BMC Ophthalmology, Vol 20, Iss 1, Pp 1-9 (2020)
BMC Ophthalmology, Vol 20, Iss 1, Pp 1-9 (2020)
Background It is not clear whether macular laser combined with anti-vascular endothelial growth factor (VEGF) can reduce the number of anti-VEGF injections in the treatment of macular edema (ME) secondary to branch retinal vein occlusion (BRVO). Our
Publikováno v:
BMC Ophthalmology
BMC Ophthalmology, Vol 20, Iss 1, Pp 1-7 (2020)
BMC Ophthalmology, Vol 20, Iss 1, Pp 1-7 (2020)
Background The development of ghost cell glaucoma in patients with proliferative diabetic retinopathy (PDR) after intravitreous injection (IV) was rare. Here we reported a series of patients with PDR who received Intravitreous Ranibizumab (IVR) and d
Publikováno v:
BMC Ophthalmology
BMC Ophthalmology, Vol 20, Iss 1, Pp 1-5 (2020)
BMC Ophthalmology, Vol 20, Iss 1, Pp 1-5 (2020)
Background To report a bilateral cystoid macular edema associated with Henoch-Schonleinpurpura. Case presentation A 21-year-old man presented a bilateral, painless, and bilateral blurred vision for 5 weeks with visual acuity (VA) of 6/12 on the right
Autor:
Justus G. Garweg, Boris Gekkiev, Giovanni Staurenghi, Bianca S. Gerendas, Philippe Margaron, Wayne Macfadden, Petr Kolar, Cornelia Dunger-Baldauf
Publikováno v:
BMC Ophthalmology
BMC Ophthalmology, Vol 20, Iss 1, Pp 1-11 (2020)
BMC Ophthalmology, Vol 20, Iss 1, Pp 1-11 (2020)
Background To evaluate the efficacy and safety of two individualized ranibizumab retreatment schemes in neovascular age-related macular degeneration. Methods Patients (N = 671) were randomized (1:1) to receive three initial monthly ranibizumab 0.5 mg
Publikováno v:
BMC Ophthalmology
BMC Ophthalmology, Vol 19, Iss 1, Pp 1-4 (2019)
BMC Ophthalmology, Vol 19, Iss 1, Pp 1-4 (2019)
Background The relationship between anti-estrogen drugs and macular telangiectasia type 2 (MacTel-2) remains unknown. Here we report a case with anti-estrogen maculopathy resembling MacTel-2 with improved visual function and macular morphology follow
Publikováno v:
BMC Ophthalmology
BMC Ophthalmology, Vol 19, Iss 1, Pp 1-5 (2019)
BMC Ophthalmology, Vol 19, Iss 1, Pp 1-5 (2019)
Background Granulomatosis with polyangiitis (GPA) is an antineutrophil cytoplasmic antibodies (ANCA)-associated necrotizing granulomatous vasculitis that affects small to medium size vessels. While the classical form with renal and respiratory tract
Publikováno v:
BMC Ophthalmology
BMC Ophthalmology, Vol 18, Iss 1, Pp 1-9 (2018)
BMC Ophthalmology, Vol 18, Iss 1, Pp 1-9 (2018)
Background This study sought to identify factors associated with retinal detachment and retreatment of aggressive posterior retinopathy of prematurity (APROP) initially treated with intravitreal ranibizumab (IVR) injection as well as the efficacy of